Mariam Alatrach
The University of Texas MD Anderson Cancer Center(US)The University of Texas Health Science Center at San Antonio(US)University Health System(US)Texas Diabetes Institute(US)
Publications by Year
Research Areas
Diabetes Treatment and Management, Metabolism, Diabetes, and Cancer, Pancreatic function and diabetes, Liver Disease Diagnosis and Treatment, Diabetes Management and Research
Most-Cited Works
- → Combination therapy with pioglitazone/exenatide/metformin reduces the prevalence of hepatic fibrosis and steatosis: The efficacy and durability of initial combination therapy for type 2 diabetes ( EDICT )(2022)41 cited
- → Evidence Against an Important Role of Plasma Insulin and Glucagon Concentrations in the Increase in EGP Caused by SGLT2 Inhibitors(2020)33 cited
- → Increase in Endogenous Glucose Production With SGLT2 Inhibition Is Unchanged by Renal Denervation and Correlates Strongly With the Increase in Urinary Glucose Excretion(2020)27 cited
- → Glucose-Mediated Glucose Disposal at Baseline Insulin Is Impaired in IFG(2018)19 cited
- → Decreased basal hepatic glucose uptake in impaired fasting glucose(2017)15 cited
- → Bromocriptine-QR Therapy Reduces Sympathetic Tone and Ameliorates a Pro-Oxidative/Pro-Inflammatory Phenotype in Peripheral Blood Mononuclear Cells and Plasma of Type 2 Diabetes Subjects(2022)